Related Experiment Video
Updated: Feb 5, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Prevalence of Hypercholesterolemia, High LDL, and Low HDL in Iran: A Systematic Review and Meta-Analysis
Mehdi Akbartabar Toori1, Faezeh Kiani2, Fatemeh Sayehmiri3
1Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Insights
Dyslipidemia, characterized by abnormal lipid levels, is prevalent in Iran, posing significant cardiovascular disease risks. This meta-analysis highlights the substantial burden of high cholesterol, LDL, and low HDL, particularly in women, emphasizing the need for better disease management.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Dyslipidemia, including elevated total cholesterol, LDL cholesterol, and reduced HDL cholesterol, is a major risk factor for cardiovascular diseases.
- Abnormal lipid profiles contribute to vessel constriction and abstraction, particularly affecting the heart.
- Understanding the prevalence of dyslipidemia is crucial for public health strategies in Iran.
Purpose of the Study:
- To estimate the prevalence of various types of dyslipidemia in Iran using a meta-analysis approach.
- To identify the scope of lipid profile abnormalities within the Iranian population.
- To provide data for targeted interventions to mitigate cardiovascular disease risks.
Main Methods:
- A comprehensive literature search was conducted across Persian and English databases (1998-2015).
- Keywords included 'lipid', 'dyslipidemia', 'CVD', 'cardiovascular risk factors', 'hypercholesterolemia', 'high LDL-C', 'low HDL-C', and 'prevalence'.
- A random-effects model was employed for data analysis using STATA software.
Main Results:
- The pooled prevalence for high cholesterol (≥200 mg/dl) was 42% and for high LDL-C (≥130 mg/dl) was 40%.
- The prevalence of low HDL-C (<40 mg/dl in males, <50 mg/dl in females) was 43%.
- All forms of dyslipidemia were found to be more prevalent in women compared to men.
Conclusions:
- The prevalence of dyslipidemia in Iran is substantial, indicating a significant public health concern.
- Addressing dyslipidemia is critical to reduce the burden of cardiovascular diseases and their complications in Iran.
- Targeted interventions and improved management strategies are necessary for Iranian populations.
Background:
Chronic and abnormal increase of different types of dyslipidemia leads to some important diseases, such as constriction and abstraction of vessels in various parts of the body, especially in the heart. High lipid profile, such as increased total cholesterol and LDL as well as decreased HDL are recognized as cardiovascular disease risk factors. The present study aimed to estimate the prevalence of different types of dyslipidemia in Iran by a meta-analysis method.
Methods:
A literature search for studies published during 1998-2015 was carried out using both Persian and English databases (SID, Magiran, IranMedex, MedLib, PubMed, and Scopus). Keywords such as lipid, dyslipidemia, CVD, cardiovascular risk factors, hypercholesterolemia, high LDL-C, low HDL-C, and prevalence were used in the search. Random-effects model was used for the analysis using STATA (version 11.2).
Results:
In total, 163 articles were identified of which 49 articles fulfilled the inclusion criteria. The estimated prevalence (95% confidence interval) of eligible articles for high cholesterol ≥200 mg/dl and ≥240 mg/dl was 42% (95% CI: 38-45) and 17% (95% CI: 14-20), respectively. Moreover, the prevalence (95% confidence interval) for high LDL-C ≥130 mg/dl and ≥160 mg/dl was 40% (95% CI: 32-48) and 19% (95% CI: 16-23), respectively. The pooled prevalence estimate for low HDL-C (<40 among males, <50 among females) was 43% (95% CI: 33-53) in both sexes of the Iranian people. All types of lipid component abnormalities (hypercholesterolemia, high LDL-C, and low HDL-C) were more prevalent in women.
Conclusion:
The results indicate that the prevalence of different types of dyslipidemia in Iran is substantial. Given the risk of complications (e.g. cardiovascular disease and control of different types of dyslipidemia) in Iranian people, it is important to reduce the burden of cardiovascular diseases.
More Related Videos
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...

